Red-state governors are taking the fight to drug industry middlemen

What has transpired in Arkansas and Louisiana should be a rallying cry to other state leaders and the constituents they swore to serve...

Opinion:

By Marion Mass

Since 2022, there have been no less than five Congressional hearings and a critical executive order from President Trump targeting the drug industry middlemen that rip off American patients – Pharmacy Benefit Managers (PBMs).

These middlemen deserve the scrutiny. Between overcharging patients and steering patients away from independ…